paclitaxel has been researched along with Diffuse Cutaneous Systemic Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chanloung, W; Kasitanon, N; Ketpueak, T; Louthrenoo, W; Nan, KN; Pongsananurak, C | 1 |
| Sugita, K; Tani, N; Yamamoto, O | 1 |
| Eisenbeilss, C; Weizel, J; Wolff, H | 1 |
1 review(s) available for paclitaxel and Diffuse Cutaneous Systemic Sclerosis
| Article | Year |
|---|---|
Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.
Topics: Acute Kidney Injury; Erythema; Female; Humans; Male; Paclitaxel; Scleroderma, Diffuse; Scleroderma, Localized; Scleroderma, Systemic; Taxoids | 2022 |
2 other study(ies) available for paclitaxel and Diffuse Cutaneous Systemic Sclerosis
| Article | Year |
|---|---|
Paclitaxel-related scleredema-like skin changes in a patient with breast cancer.
Topics: Adult; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Immunohistochemistry; Mastectomy; Paclitaxel; Risk Assessment; Scleroderma, Diffuse; Withholding Treatment | 2018 |
[Scleroderma-like skin changes following administration of paclitaxel for the treatment of ovarian carcinoma].
Topics: Diagnosis, Differential; Drug Eruptions; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Scleroderma, Diffuse; Skin | 2003 |